Welcome to LookChem.com Sign In|Join Free

CAS

  • or

57260-70-5

Post Buying Request

57260-70-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

57260-70-5 Usage

General Description

1-Boc-(4-benzyl)piperazine is an heterocyclic building block.

Check Digit Verification of cas no

The CAS Registry Mumber 57260-70-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,2,6 and 0 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 57260-70:
(7*5)+(6*7)+(5*2)+(4*6)+(3*0)+(2*7)+(1*0)=125
125 % 10 = 5
So 57260-70-5 is a valid CAS Registry Number.
InChI:InChI=1/C16H24N2O2/c1-16(2,3)20-15(19)18-11-9-17(10-12-18)13-14-7-5-4-6-8-14/h4-8H,9-13H2,1-3H3

57260-70-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L14644)  1-Benzyl-4-Boc-piperazine, 99%   

  • 57260-70-5

  • 1g

  • 210.0CNY

  • Detail
  • Alfa Aesar

  • (L14644)  1-Benzyl-4-Boc-piperazine, 99%   

  • 57260-70-5

  • 5g

  • 721.0CNY

  • Detail
  • Aldrich

  • (374830)  1-Boc-(4-benzyl)piperazine  98%

  • 57260-70-5

  • 374830-1G

  • 200.07CNY

  • Detail

57260-70-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Benzyl-4-Boc-Piperazine

1.2 Other means of identification

Product number -
Other names tert-butyl 4-benzylpiperazine-1-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:57260-70-5 SDS

57260-70-5Synthetic route

1-phenylmethylpiperazine
2759-28-6

1-phenylmethylpiperazine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

4-benzyl-piperazine-1-carboxylic acid tert-butyl ester
57260-70-5

4-benzyl-piperazine-1-carboxylic acid tert-butyl ester

Conditions
ConditionsYield
In methanol at 20℃;100%
With sodium hydrogencarbonate In 1,4-dioxane; water at 5 - 20℃; for 25h;99%
With iodine at 20℃; for 0.5h;96%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

N-benzyl-piperazine hydrochloride
110475-31-5

N-benzyl-piperazine hydrochloride

4-benzyl-piperazine-1-carboxylic acid tert-butyl ester
57260-70-5

4-benzyl-piperazine-1-carboxylic acid tert-butyl ester

Conditions
ConditionsYield
With dmap; TEA In dichloromethane for 0.25h;100%
4-benzoylpiperazine-1-carboxylic acid tert-butyl ester
77278-38-7

4-benzoylpiperazine-1-carboxylic acid tert-butyl ester

4-benzyl-piperazine-1-carboxylic acid tert-butyl ester
57260-70-5

4-benzyl-piperazine-1-carboxylic acid tert-butyl ester

Conditions
ConditionsYield
With diethylzinc; lithium chloride In tetrahydrofuran; hexane at 20℃; for 24h; Catalytic behavior; Inert atmosphere; chemoselective reaction;98%
Multi-step reaction with 2 steps
1: tris(2,6-difluorophenyl)borane triethylphosphine oxide; oxalyl dichloride / chloroform / 2 h / 50 °C / Sealed tube; Inert atmosphere; Glovebox
2: hydrogen; tris(2,6-difluorophenyl)borane triethylphosphine oxide; 2,6-dimethylpyridine / chloroform / 22 h / 70 °C / 60006 Torr / Autoclave
View Scheme
benzyl bromide
100-39-0

benzyl bromide

1-t-Butoxycarbonylpiperazine
57260-71-6

1-t-Butoxycarbonylpiperazine

4-benzyl-piperazine-1-carboxylic acid tert-butyl ester
57260-70-5

4-benzyl-piperazine-1-carboxylic acid tert-butyl ester

Conditions
ConditionsYield
With N-benzyl-trimethylammonium hydroxide at 20℃; Neat (no solvent);96%
With triethylamine In acetonitrile at 0 - 20℃; for 0.6h;76%
With potassium carbonate In dichloromethane for 10h; Reflux; Inert atmosphere;69%

57260-70-5Relevant articles and documents

Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity

Albanese, Valentina,Ruzza, Chiara,Marzola, Erika,Bernardi, Tatiana,Fabbri, Martina,Fantinati, Anna,Trapella, Claudio,Reinscheid, Rainer K.,Ferrari, Federica,Sturaro, Chiara,Calò, Girolamo,Amendola, Giorgio,Cosconati, Sandro,Pacifico, Salvatore,Guerrini, Remo,Preti, Delia

, p. 4089 - 4108 (2021/04/12)

Neuropeptide S modulates important neurobiological functions including locomotion, anxiety, and drug abuse through interaction with its G protein-coupled receptor known as neuropeptide S receptor (NPSR). NPSR antagonists are potentially useful for the treatment of substance abuse disorders against which there is an urgent need for new effective therapeutic approaches. Potent NPSR antagonists in vitro have been discovered which, however, require further optimization of their in vivo pharmacological profile. This work describes a new series of NPSR antagonists of the oxazolo[3,4-a]pyrazine class. The guanidine derivative 16 exhibited nanomolar activity in vitro and 5-fold improved potency in vivo compared to SHA-68, a reference pharmacological tool in this field. Compound 16 can be considered a new tool for research studies on the translational potential of the NPSergic system. An in-depth molecular modeling investigation was also performed to gain new insights into the observed structure-activity relationships and provide an updated model of ligand/NPSR interactions.

Identification of a novel neuropeptide s receptor antagonist scaffold based on the sha-68 core

Bool, Heather,Clark, Stewart D.,Gay, Elaine,Jahan, Rajwana,Jewula, Gabriel,McElhinny, Charles,Runyon, Scott,Snyder, Rodney,Uprety, Rajendra,Zarkin, Allison,Zhang, Yanan

, (2021/10/20)

Activation of the neuropeptide S receptor (NPSR) system has been shown to produce an-xiolytic-like actions, arousal, and enhance memory consolidation, whereas blockade of the NPSR has been shown to reduce relapse to substances of abuse and duration of anesthetics. We report here the discovery of a novel core scaffold (+) N-benzyl-3-(2-methylpropyl)-1-oxo-3-phenyl-1H,3H,4H,5H,6H,7H-furo[3,4-c]pyridine-5-carboxamide with potent NPSR antagonist activity in vitro. Pharmacokinetic parameters demonstrate that 14b reaches pharmacologically relevant levels in plasma and the brain following intraperitoneal (i.p.) administration, but is cleared rapidly from plasma. Compound 14b was able to block NPS (0.3 nmol)-stimulated locomotor activity in C57/Bl6 mice at 3 mg/kg (i.p.), indicating potent in vivo activity for the structural class. This suggests that 14b can serve as a useful tool for continued mapping of the pharmacological functions of the NPS receptor system.

An Improved Stereocontrolled Access Route to Piperidine or Azepane β-Amino Esters and Azabicyclic β- and γ-Lactams; Synthesis of Novel Functionalized Azaheterocyles

Ouchakour, Lamiaa,Nonn, Melinda,Remete, Attila M.,Kiss, Loránd

, p. 3874 - 3885 (2021/06/16)

An improved, efficient synthesis of some functionalized saturated azaheterocycles has been accomplished by controlled functionalization of various readily available cyclic compounds containing ring C=C bond. The stereocontrolled synthetic concept was based on the oxidative ring cleavage of various unsaturated scaffolds across ozonolysis followed by ring closing with double reductive amination with primary alkylamines or fluorinated alkylamines. The protocol provided versatile azaheterocyclic derivatives with a piperidine or azepane framework.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 57260-70-5